Navigation Links
HearAtLast Announces Completion of Initial Private Placement Financing Totaling US $1,000,000
Date:11/26/2007

TORONTO, Nov. 26 /PRNewswire-FirstCall/ -- (OTC Pinksheets: HRAL)- HearAtLast Holdings, Inc. announced today that it has completed a US $1 million private placement of its restricted common stock. On November 2, 2007, the Company closed its initial round of private equity financing since going public (commonly referred to as a "PIPE" transaction), and obtained investment funds from accredited investors in the aggregate sum of US $1,000,000 for the purchase of 666,667 shares of the Company's restricted common stock, which represents a purchase price of $1.50 per share. The private equity investors have agreed to a contractual two year "lock-up" on re-sale of the shares in the public market, terms which management believes are very favorable to the Company and its current shareholders.

HearAtLast management is pleased to point out that the PIPE funding terms negotiated are simple stock purchase agreements with no convertible features, warrants, stock options or any type of preferred securitization. All common stock sold in these two transactions will bear a two year restriction and holders of such securities are restricted from selling their stock pursuant to rule 144 prior to the two year anniversary of the stock purchase date. The Company is not subject to any "death spiral" or dilutive terms in these straight forward restricted stock purchase agreements.

As a condition of the private placements, HearAtLast CEO, Matteo Sacco, has agreed to return to treasury and cancel the like amount of 666,667 shares of the Company's common stock he currently holds, to eliminate any dilution to the current HearAtLast shareholders.

"This initial funding tranche will provide us with the necessary capital to continue the aggressive expansion set forth in our business plan," stated Matteo Sacco, CEO of HearAtLast. "We could not be more pleased with the terms of these agreements as it demonstrates the long term commitment and overall confidence that these funders have in our company," Mr. Sacco added.

About HearAtLast

HearAtLast Holdings, Inc. is a Nevada corporation that owns and operates its wholly-owned subsidiary HearAtLast Inc., a chain of hearing stores specializing in the sale of digital hearing aids and testing services. The company develops, owns, and operates hearing aid clinics co-located within select Wal-Mart stores throughout Canada. HearAtLast facilities sell a selection of high quality brand name hearing aids and also offer complimentary screening tests, clinical hearing tests, instant custom MP3 headphones and custom hearing protection. The Company's mission is to consolidate the highly fragmented hearing services industry while providing unparalleled service to the estimated 30+ million hearing impaired individuals throughout North America. After a prescription is approved, the independent on-site audiologists and hearing aid practitioners at HearAtLast utilize a refined process to dispense a hearing aid in about an hour.

For more information please visit http://www.hearatlast.com

Safe Harbor

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward- looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward- looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

Investor Relations:

Stephen Taylor

Taylor Capitol, Inc.

Email: STEPHTAYL9@AOL.COM

Office: (973) 351-3868


'/>"/>
SOURCE HearAtLast Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Harbinger Research Initiates Coverage on HearAtLast
2. HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053
3. HearAtLast Teams Up with American Express and Wal-Mart to Conquer Hearing Loss
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that ... Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains ... lens flare and light leak transitions have a very high-dynamic range for super smooth ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “The Land of ... attention to the issue of world hunger, and shares the simple and achievable answer. ... devoted husband and member of the Fairview Missionary Church in Angola, Indiana where he ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... and facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. ... of physicians and patients throughout the United States for high-quality human anti-aging ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound ... extension to RMT technology that delivers HD, dynamic, streaming ultrasound images and video ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... New Therapeutic Option to Address Motor Symptoms and ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Fabrizio Stocchi , European Neurological Review,2016;11(Suppl. 2): 2-15, ...
Breaking Medicine Technology: